Section XIII
(41 k) (36 k) (54 k) (46 k) (41 k) (28 k) (29 k) (31 k) (28 k) (29 k) (31 k) (31 k) (31 k) (30 k) (30 k) (65 k) (36 k) (22 k) (42 k) (22 k) (36 k) (22 k) (41 k) (22 k) (40 k) (47 k) | View HTML | View PDF | |
|---|---|---|
Section XIII | ||
| 13.1a | Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1997 to 2006 | (41 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 13.1b | Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active and Inactive Patient Comparison, 2002 to 2006 | (36 k) |
| Age | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| Time on Waiting List | ||
| 13.2 | Time to Transplant, 1997 to 2006 New Heart-Lung Waiting List Registrations | (54 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| 13.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Heart-Lung Waiting List | (46 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| 13.4 | Transplant Recipient Characteristics, 1997 to 2006 Heart-Lung Recipients | (41 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 13.5 | Incidence of Transplant, 1997 to 2006 Heart-Lung Transplants per 1 Million Population | (28 k) |
| 13.6a | Immunosuppression Use for Induction, 1997 to 2006 Recipients with Heart-Lung Transplants | (29 k) |
| 13.6b | Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Heart-Lung Transplants | (31 k) |
| 13.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Heart-Lung Transplants | (28 k) |
| 13.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Heart-Lung Transplants | (29 k) |
| 13.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Heart-Lung Transplants | (31 k) |
| 13.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Heart-Lung Transplants | (31 k) |
| 13.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Heart-Lung Transplants | (31 k) |
| 13.6h | Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Heart-Lung Transplants | (30 k) |
| 13.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Heart-Lung Transplantation | (65 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Any Organ | ||
| Diagnosis | ||
| 13.8 | Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (36 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| 13.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.10 | Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (42 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| 13.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.12 | Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (36 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| 13.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.14 | Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (41 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| 13.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.16 | Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1997 to 2005 | (40 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 13.17 | Transplants by State and Transplant Center, 1997 to 2006 Heart-Lung | (47 k) |